(NHS) Neuberger Berman High Yield - Ratings and Ratios

Neuberger Berman High Yield Strategies (NHS) is a high-yield bond fund listed on the NYSE MKT exchange. As a high-yield bond fund, NHS invests in a portfolio of lower-rated, higher-yielding debt securities, aiming to provide investors with regular income and potentially higher returns compared to investment-grade bonds.

To evaluate NHSs performance, key performance indicators (KPIs) such as yield, duration, and credit quality are essential. The funds yield, for instance, can be compared to its benchmark to assess its income-generating capability. A higher yield may indicate a more attractive income stream, but it also implies higher risk. NHSs duration, which measures its sensitivity to interest rate changes, is another crucial metric. A fund with a longer duration is more vulnerable to interest rate fluctuations.

The funds credit quality is also vital, as it directly impacts the likelihood of default. NHSs portfolio is likely comprised of bonds with lower credit ratings, which increases the risk of default. To mitigate this risk, the funds management team may employ various strategies, such as diversification across industries and issuers. Investors should monitor NHSs credit quality and adjust their expectations accordingly.

In terms of its assets under management (AUM), NHS has approximately $206.54 million in assets, indicating a moderate size that allows for some economies of scale while still maintaining a relatively focused investment approach. This AUM figure can be used to assess the funds liquidity and potential for growth.

To make informed investment decisions, its essential to analyze NHSs performance in the context of the broader high-yield bond market. By comparing NHSs KPIs to those of its peers and benchmark, investors can gain a deeper understanding of the funds strengths and weaknesses, ultimately determining whether it aligns with their investment objectives and risk tolerance.